Janssen is one of the world’s leading research-based pharmaceutical organisations and is part of the Johnson & Johnson family of companies, the largest diversified healthcare group in the world with over 100 years of scientific heritage. We have access to a global pool of resources and talent which allows us to continue our pioneering work in discovering innovative medicines to improve patients’ lives and to follow in the footsteps of our founder Dr. Paul Janssen who famously said, "patients are waiting".
Governments across the world will have to face up to the challenges posed by the hepatitis C (HCV) pandemic or experience spiralling healthcare costs, says the Economist Intelligence Unit in its report The silent pandemic: Tackling hepatitis C with policy..
New research carried out during Movember among family members of those living with prostate cancer today reveals the impact of chemotherapy on patients ahead of World Cancer Day (Feb 4th). The study supported by Janssen shows chemotherapy brought major changes in..
Johnson & Johnson has announced that the Company, through its subsidiary Janssen Research and Development, LLC, has entered into a novel agreement with Yale School of Medicine’s Open Data Access (YODA) Project to extend its commitment to sharing clinical trials..